LogicBio Therapeutics, Inc. Proceeds from Stock Options Exercised
LogicBio Therapeutics, Inc. reported Proceeds from Stock Options Exercised of $87.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-04.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2022-11-14
- LogicBio Therapeutics, Inc. proceeds from stock options exercised for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- LogicBio Therapeutics, Inc. proceeds from stock options exercised for the quarter ending 2021-09-30 was $35.00K.
- LogicBio Therapeutics, Inc. proceeds from stock options exercised for the quarter ending 2020-12-31 was $2.00K, a 97.53% decline year-over-year.
- LogicBio Therapeutics, Inc. proceeds from stock options exercised for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- LogicBio Therapeutics, Inc. proceeds from stock options exercised for fiscal 2021 was $87.00K, a 1.16% increase from fiscal 2020.
- LogicBio Therapeutics, Inc. proceeds from stock options exercised for fiscal 2020 was $86.00K, a 61.61% decline from fiscal 2019.
- LogicBio Therapeutics, Inc. proceeds from stock options exercised for fiscal 2019 was $224.00K, a 1020.00% increase from fiscal 2018.
- LogicBio Therapeutics, Inc. proceeds from stock options exercised for fiscal 2018 was $20.00K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $35.00K derived: sum of 2 quarters · filed 2022-11-14 | $87.00K 10-K · filed 2022-03-04 | |
| 2021-09-30 | $35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $87.00K 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $52.00K 10-Q · filed 2022-08-15 | |||
| 2020-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $2.00K derived: sum of 2 quarters · filed 2022-03-04 | $2.00K derived: sum of 3 quarters · filed 2022-03-04 | $86.00K 10-K · filed 2022-03-04 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $84.00K 10-Q · filed 2021-11-15 | $165.00K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $84.00K 10-Q · filed 2021-08-09 | $165.00K derived: sum of 3 quarters · filed 2021-08-09 | $226.00K derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | $84.00K 10-Q · filed 2021-05-10 | $165.00K derived: sum of 2 quarters · filed 2021-05-10 | $226.00K derived: sum of 3 quarters · filed 2021-05-10 | |
| 2019-12-31 | $81.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $142.00K derived: sum of 2 quarters · filed 2021-03-15 | $224.00K 10-K · filed 2021-03-15 | |
| 2019-09-30 | $61.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $143.00K 10-Q · filed 2020-11-09 | ||
| 2019-06-30 | $82.00K 10-Q · filed 2020-08-10 | |||
| 2018-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $20.00K 10-K · filed 2020-03-16 | ||
| 2018-09-30 | $11.00K 10-Q · filed 2019-11-12 |